MedTrace Logo

Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies

NCT02934295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2017-02-01

No results posted yet for this study

Summary

The aim of the research is to study humoral and cellular immunity in pregnant women for who the level of rubella virus antibodies is weakly positive, equivocal or negative with the usual laboratory technique.

Conditions

  • Pregnancy

Interventions

BIOLOGICAL

Determination of Anti-Rubella Antibody, E1

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Olivier Picone · Hôpital Foch

  • Christelle VAULOUP-FELLOUS, MD · Hôpital Brousse

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-05-31
Completion
2014-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934295 on ClinicalTrials.gov